BRPI0907485A2 - Polipeptídeos de ligação a antígeno contra degeneração de cartilagem - Google Patents

Polipeptídeos de ligação a antígeno contra degeneração de cartilagem

Info

Publication number
BRPI0907485A2
BRPI0907485A2 BRPI0907485-6A BRPI0907485A BRPI0907485A2 BR PI0907485 A2 BRPI0907485 A2 BR PI0907485A2 BR PI0907485 A BRPI0907485 A BR PI0907485A BR PI0907485 A2 BRPI0907485 A2 BR PI0907485A2
Authority
BR
Brazil
Prior art keywords
antigen
binding polypeptides
cartilage degeneration
polypeptides against
against cartilage
Prior art date
Application number
BRPI0907485-6A
Other languages
English (en)
Inventor
David Urech
Peter Lichtlen
Original Assignee
Delenex Therapeutics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delenex Therapeutics Ag filed Critical Delenex Therapeutics Ag
Publication of BRPI0907485A2 publication Critical patent/BRPI0907485A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0907485-6A 2008-02-05 2009-02-05 Polipeptídeos de ligação a antígeno contra degeneração de cartilagem BRPI0907485A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2631708P 2008-02-05 2008-02-05
US8887608P 2008-08-14 2008-08-14
PCT/CH2009/000045 WO2009097704A1 (en) 2008-02-05 2009-02-05 Antigen-binding polypeptides against cartilage degeneration

Publications (1)

Publication Number Publication Date
BRPI0907485A2 true BRPI0907485A2 (pt) 2015-08-04

Family

ID=40568129

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907485-6A BRPI0907485A2 (pt) 2008-02-05 2009-02-05 Polipeptídeos de ligação a antígeno contra degeneração de cartilagem

Country Status (10)

Country Link
US (1) US20110002927A1 (pt)
EP (1) EP2240515A1 (pt)
JP (1) JP2011510667A (pt)
CN (1) CN101939335B (pt)
AU (1) AU2009212079B2 (pt)
BR (1) BRPI0907485A2 (pt)
CA (1) CA2712965A1 (pt)
IL (1) IL206720A0 (pt)
RU (1) RU2010136988A (pt)
WO (1) WO2009097704A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012040623A2 (en) 2010-09-24 2012-03-29 The Brigham And Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
CN104231086B (zh) * 2013-08-27 2019-12-13 北京韩美药品有限公司 双功能融合蛋白及其制备方法和用途
SG11201604227XA (en) 2013-12-13 2016-07-28 Mercury Asset Man Co Ltd Articular cartilage imaging composition
CN115837006A (zh) * 2016-05-06 2023-03-24 布里格姆及妇女医院股份有限公司 用于向软骨中受控递送被囊封的药剂的二元自组装凝胶
JP7323608B2 (ja) 2018-10-11 2023-08-08 アリヴィオ セラピューティクス， インコーポレイテッド スマート放出のための非注射用ヒドロゲル製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0013810D0 (en) * 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
WO2006131013A2 (en) * 2005-06-07 2006-12-14 Esbatech Ag STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα
ES2820837T3 (es) * 2006-07-10 2021-04-22 Esbatech Alcon Biomed Res Unit Anticuerpos scFv que pasan las capas epitelial y/o endotelial

Also Published As

Publication number Publication date
WO2009097704A1 (en) 2009-08-13
CA2712965A1 (en) 2009-08-13
JP2011510667A (ja) 2011-04-07
AU2009212079A1 (en) 2009-08-13
IL206720A0 (en) 2010-12-30
RU2010136988A (ru) 2012-03-20
EP2240515A1 (en) 2010-10-20
CN101939335A (zh) 2011-01-05
AU2009212079B2 (en) 2012-08-30
CN101939335B (zh) 2015-02-11
US20110002927A1 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
DK2240454T3 (da) Mesoioniske pesticider
BRPI0911695A2 (pt) conjunto de barbear
BRPI1012605A2 (pt) método de limpeza
DK2252395T3 (da) Afsvovlingsmaterialer
BRPI0921153A2 (pt) reforço de armadura
DK2366113T3 (da) Dgnss-korrektion til positionering
BRPI0922463A2 (pt) encaixe de nervura
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0918249A2 (pt) prótese
BRPI0909036A2 (pt) pesticidas
BRPI0913321A2 (pt) transportador de peça
FR2935592B1 (fr) Poudrier
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0908535A2 (pt) configuração de vedação
BRPI1008921A2 (pt) cabeçote de impressão
DK2382224T3 (da) Metalhydracid-materialer
DK2315743T3 (da) Fremgangsmåde til oprensning af dialkylsulfider
BRPI0924738A2 (pt) Herbicidas
BRPI0907485A2 (pt) Polipeptídeos de ligação a antígeno contra degeneração de cartilagem
BRPI0909106A2 (pt) Método herbicida
FI20086251A0 (fi) Siivousväline
BR112012004236A2 (pt) restauração de cartilagem
BRPI0920116A2 (pt) membro de vedação
BRPI1011446A2 (pt) unidade de dosagem para cip/sipit
DK2257166T3 (da) Herbicid-kombinationer indeholdende diflufenican

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]